Insider selling
Traded Jun 16 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −57.2% · S&P 500 −8.1% · to Nov 20
A Dermata Therapeutics director sold $13 of Dermata Therapeutics shares. The filing does not indicate a pre-arranged trading plan.